Literature DB >> 2466565

Signalling pathway of tumor necrosis factor in normal and tumor cells.

N Watanabe1, H Neda, Y Ohtusuka, H Sone, N Yamauchi, M Maeda, H Kuriyama, Y Niitsu.   

Abstract

Several aspects of the activity and effects of tumor necrosis factor (TNF) were investigated to gain further insight into its cytotoxic mechanism. The relation between number of TNF receptors and TNF susceptibility of both tumor cells and normal cells was studied, utilizing a specific binding assay. Among the tumor cells, a fairly close correlation (r = 0.855) was observed between receptor number and sensitivity to TNF. No cytotoxic effect by TNF was observed on any of the normal cells tested, even though TNF receptors were shown to be present, and cell proliferation was apparently stimulated by TNF in some cases. TNF internalization and intracellular distribution were studied by pulse-labelling and Percoll density gradient centrifugation. In L-M (murine tumorigenic fibroblasts, highly sensitive to TNF cytotoxicity) cells and HEL (human embryonic lung cells, non-sensitive to TNF cytotoxicity) cells, receptor-bound 125I-labelled recombinant human TNF was rapidly internalized and delivered to lysosomes within 15-30 min, and this was followed by degradation and release into the culture medium. The presence of either a cytoskeletal disrupting agent or a lysosomotropic agent was observed to inhibit the cytotoxic effect of TNF, thus also indicating that TNF internalization, followed by delivery to lysosomes, is essential in the cytolytic mechanism of TNF. As observed by [3H]uridine incorporation, TNF did not affect RNA synthesis in L-R cells (TNF-resistant cell lines derived from L-M cells) and HEL cells, but markedly stimulated (by 3.5 times) RNA synthesis in L-M cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466565     DOI: 10.1007/bf00204983

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  38 in total

1.  Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor.

Authors:  S Yamazaki; E Onishi; K Enami; K Natori; M Kohase; H Sakamoto; M Tanouchi; H Hayashi
Journal:  Jpn J Med Sci Biol       Date:  1986-06

2.  Analysis of the TNF receptor on KYM cells by binding assay and affinity cross-linking.

Authors:  Y Niitsu; N Watanabe; H Sone; H Neda; N Yamauchi; M Maeda; I Urushizaki
Journal:  J Biol Response Mod       Date:  1988-06

3.  Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum.

Authors:  F C Kull; P Cuatrecasas
Journal:  Cancer Res       Date:  1981-12       Impact factor: 12.701

4.  Characterization and affinity crosslinking of receptors for tumor necrosis factor on human cells.

Authors:  M Tsujimoto; R Feinman; M Kohase; J Vilcek
Journal:  Arch Biochem Biophys       Date:  1986-09       Impact factor: 4.013

5.  Dual pathways for epidermal growth factor processing after receptor-mediated endocytosis.

Authors:  W K Miskimins; N Shimizu
Journal:  J Cell Physiol       Date:  1982-09       Impact factor: 6.384

6.  Cell surface receptor-mediated internalization of interferon: its relation to the antiviral activity of interferon.

Authors:  S Yonehara; A Ishii; M Yonehara-Takahashi
Journal:  J Gen Virol       Date:  1983-11       Impact factor: 3.891

7.  Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.

Authors:  M Tsujimoto; Y K Yip; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

8.  Regulation of macrophage tumor necrosis factor production by prostaglandin E2.

Authors:  S L Kunkel; R C Wiggins; S W Chensue; J Larrick
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

9.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

10.  Tumour-necrosis factor from the rabbit. II. Production by monocytes.

Authors:  N Matthews
Journal:  Br J Cancer       Date:  1978-08       Impact factor: 7.640

View more
  6 in total

1.  Colchicine prevents tumor necrosis factor-induced toxicity in vivo.

Authors:  G Tiegs; M A Freudenberg; C Galanos; A Wendel
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

2.  Enhancement of lysosomal enzyme activity by recombinant human tumor necrosis factor and its role in tumor cell killing in vitro.

Authors:  N Watanabe; N Yamauchi; H Neda; M Maeda; Y Tsuji; T Okamoto; S Akiyama; H Sasaki; N Tsuji; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1992-06

3.  Reversal of tumor necrosis factor resistance in tumor cells by adriamycin via suppression of intracellular resistance factors.

Authors:  N Watanabe; T Okamoto; N Tsuji; H Sasaki; S Akiyama; D Kobayashi; T Sato; N Yamauchi; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1995-04

4.  Lysosome labilizers potentiate the antitumor effects of tumor necrosis factor-alpha.

Authors:  T Masegi; A Kato; K Kitai; M Fukuoka; K Soma; Y Ichikawa; S Nakamura; N Watanabe; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1993-04

5.  Augmented systemic immunity in mice implanted with tumor necrosis factor-alpha gene-transduced Meth-A-cells.

Authors:  S Fujii; Y Liu; H Neda; Y Itoh; Y Koshita; M Takahashi; N Watanabe; Y Kohgo; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1994-03

6.  Mechanism of synergistic cytotoxic effect between tumor necrosis factor and hyperthermia.

Authors:  N Yamauchi; N Watanabe; M Maeda; T Okamoto; H Sasaki; N Tsuji; Y Tsuji; H Umeno; S Akiyama; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1992-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.